ro3201195
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- MAP kinase p38 alphaINHIBITOR
MAPK14 inhibitor
Binds to both p38a (MAPK14) and p38ß (MAPK11) isoforms
Chemistry & pharmacology
Loading structure…
SMILES
Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1- Mol. weight
- 371.37 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL203567 ↗
Also known as
- 5-amino-1-(4-fluorophenyl)-4-(3-(2,3-dihydroxypropoxy)benzoyl)pyrazole
- ro3201195
- ro 3201195
- ro-3201195
- ro-3201195
- ro-3201195